Resmed RSMDF
NYSE RSMDF
$22.61 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Resmed (RSMDF) Non Operating Income (2009 - 2026)

Resmed's (RSMDF) quarterly Non Operating Income came in at $25.5 million in Q2 2026, up 624.51% on a YoY basis from $3.5 million in Q2 2025, and up 917.27% quarter-over-quarter from $2.5 million in Q1 2026.

Analysis

Resmed (RSMDF) Non Operating Income (2009 - 2026) Analysis & Trends

Resmed (RSMDF) has reported Non Operating Income for 18 consecutive years, with $25.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non Operating Income rose 624.51% year-over-year to $25.5 million; the trailing twelve-month figure through Jun 2026 stood at $32.7 million (up 519.31% YoY), and the FY2026 full-year result was $32.7 million, up 519.4% from the prior year.
  • Non Operating Income grew to $25.5 million in Q2 2026 per RSMDF's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $25.5 million in Q2 2026 and bottomed at -$23.5 million in Q2 2024.
  • Historically, Non Operating Income has averaged -$4.8 million across 5 years, with a median of -$5.2 million in 2022.
  • The sharpest annual moves came in 2024 and 2026: Non Operating Income slumped 1631.9% in 2024, then jumped 624.51% in 2026.
  • Over 5 years, Non Operating Income stood at -$6.5 million in 2022, then slumped by 140.5% to -$15.6 million in 2023, then soared by 106.9% to $1.1 million in 2024, then soared by 315.94% to $4.5 million in 2025, then soared by 467.11% to $25.5 million in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $25.5 million, $2.5 million, and $4.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Abbott Laboratories 185.05 Bn 179.45 Bn 7.27 Bn -
2 Intuitive Surgical 124.43 Bn 119.22 Bn 1.96 Bn 82.70 Mn
3 Medtronic 118.52 Bn 109.70 Bn 6.34 Bn -
4 Stryker 104.55 Bn 101.07 Bn 4.50 Bn 46.00 Mn
5 Boston Scientific 67.11 Bn 66.57 Bn 3.85 Bn -
6 Edwards Lifesciences 49.85 Bn 45.60 Bn 1.35 Bn 6.60 Mn
7 Alcon 33.97 Bn 32.52 Bn 1.68 Bn -
8 Dexcom 32.28 Bn 30.33 Bn 830.00 Mn -
9 Steris 21.15 Bn 20.67 Bn 684.20 Mn -12.30 Mn
10 Resmed 3.54 Bn 2.07 Bn 861.22 Mn 25.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.45 Mn
Mar 31, 2026 2.50 Mn
Dec 31, 2025 4.49 Mn
Sep 30, 2025 256,000.00
Jun 30, 2025 3.51 Mn
Mar 31, 2025 -8.58 Mn
Dec 31, 2024 1.08 Mn
Sep 30, 2024 -3.82 Mn
Jun 30, 2024 -23.48 Mn
Mar 31, 2024 837,000.00
Dec 31, 2023 -15.64 Mn
Sep 30, 2023 -16.81 Mn
Jun 30, 2023 1.53 Mn
Mar 31, 2023 -11.29 Mn
Dec 31, 2022 -6.50 Mn
Sep 30, 2022 -13.95 Mn
Jun 30, 2022 -17.31 Mn
Mar 31, 2022 -7.95 Mn
Dec 31, 2021 -11.43 Mn
Sep 30, 2021 -3.13 Mn